Recent developments in the mutational landscape and molecular basis of AML
Why should elderly AML patients take part in clinical trials?
The IMPACT Trials Network for improving outcomes for stem cell transplant patients
Getting specific with myeloma therapy: selecting the right treatments
How to overcome resistance to new compounds in CLL